McKesson Corporation
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IE
US
US
US
US
IN
US
US
US
US
US
US
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Track McKesson Corporation in real time with a live news feed covering McKesson Corporation stock news, official press releases, company announcements, and an archive of historical McKesson Corporation news. ...more
Loading news...
Loading more...
3:57 AM | Saturday | Aug 29, 2026
Sign in to download news snippet
Beacon Pointe Advisors LLC purchased a new position in shares of McKesson Corporation (NYSE: MCK) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 20,343 shares of the company's stock, valued at approximately $15,371,000. A number of other hedge funds and
Read full articleNo data available for this time period.
Change the time range to see results.
Beacon Pointe Advisors LLC purchased a new position in shares of McKesson Corporation (NYSE: MCK) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 20,343 shares of the company's stock, valued at approximately $15,371,000. A number of other hedge funds and
Read full articleMCK's $2.25B Precision Medicine Group deal aims to expand clinical research and commercialization services in oncology and multispecialty care.
Read full article
McKesson Corporation (NYSE:MCK) on Tuesday announced an agreement to acquire Precision Medicine Group.
Read full article
U.S. drug distributor McKesson said on Tuesday it would buy clinical research and biopharma commercialization services provider Precision Medicine Group in a deal valued at about $2.25 billion.
Read full article
McKesson raises fiscal 2027 EPS guidance as oncology, GLP-1 volumes and specialty distribution drive faster profit growth despite cash-flow pressure.
Read full article
McKesson's double-digit earnings growth, specialty expansion and capital returns support the story, but a premium valuation leaves less room for error.
Read full article
Algebris UK Ltd. bought a new stake in McKesson Corporation (NYSE: MCK) during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,206 shares of the company's stock, valued at approximately $908,000. Other institutional investors and hedge funds have also added to
Read full article
Aurora Investment Counsel purchased a new stake in shares of McKesson Corporation (NYSE: MCK) in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 2,797 shares of the company's stock, valued at approximately $2,113,000. A number of other institutional investors and hedge
Read full article
These healthcare companies can actually benefit from inflation.
Read full article
Alamar Capital Management LLC bought a new position in McKesson Corporation (NYSE: MCK) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 1,844 shares of the company's stock, valued at approximately $1,395,000. A number of other large investors have also recently added
Read full article
No data available for this time period.
Change the time range to see results.